SCHEMBL8345386

SCHEMBL8345386

CCOC(OCC)c1ccc(CNCCN(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 1/20 0.38
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
PTGS2 P35354 2/20 0.37
SIGMAR1 Q99720 1/20 0.37
KDM4E B2RXH2 1/20 0.37
THRB P10828 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
OPRM1 P35372 2/20 0.37
OPRK1 P41145 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6228744 0.80 ACHE (0.42) L3MBTL1MEN1KMT2AMAPK1BCHE
SCHEMBL10054980 0.80 SIGMAR1 (0.50) MEN1KMT2ASIGMAR1TDP1OPRM1
SCHEMBL14068323 0.78 CYP1A2 (0.45) L3MBTL1KDM4ETHRBTDP1CYP1A2
SCHEMBL2356251 0.77 LMNA (0.47) L3MBTL1KDM4ETHRBTDP1CYP1A2
SCHEMBL2047868 0.75 ACHE (0.44) L3MBTL1MEN1KMT2ABCHEACHE
SCHEMBL2046392 0.75 HRH3 (0.48) ALDH1A1BCHEACHEPTGS2HRH3
SCHEMBL3037243 0.75 TAAR1 (0.57) SIGMAR1OPRM1OPRK1CYP1A2CYP2D6
SCHEMBL6203608 0.75 ALDH1A1 (0.45) MEN1KMT2AALDH1A1BCHEACHE
SCHEMBL4743388 0.73 HDAC3 (0.45) MAPK1BCHEACHEPTGS2KDM4E
SCHEMBL14739541 0.73 CHRM2 (0.42) L3MBTL1KDM4ETHRBTDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004009602-A1 PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-01-29 WO disclosed